BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 10771117)

  • 1. Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors.
    Arias HR
    Neurochem Int; 2000 Jun; 36(7):595-645. PubMed ID: 10771117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topology of ligand binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Brain Res Brain Res Rev; 1997 Oct; 25(2):133-91. PubMed ID: 9403137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the agonist-binding sites of the Torpedo nicotinic acetylcholine receptor: affinity-labeling and mutational analyses identify gamma Tyr-111/delta Arg-113 as antagonist affinity determinants.
    Chiara DC; Xie Y; Cohen JB
    Biochemistry; 1999 May; 38(20):6689-98. PubMed ID: 10350488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor.
    Arias HR
    Biochim Biophys Acta; 1998 Aug; 1376(2):173-220. PubMed ID: 9748559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of regions involved in the binding of alpha-bungarotoxin to the human alpha7 neuronal nicotinic acetylcholine receptor using synthetic peptides.
    Marinou M; Tzartos SJ
    Biochem J; 2003 Jun; 372(Pt 2):543-54. PubMed ID: 12614199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors.
    Hansen SB; Taylor P
    J Mol Biol; 2007 Jun; 369(4):895-901. PubMed ID: 17481657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinctions in agonist and antagonist specificity conferred by anionic residues of the nicotinic acetylcholine receptor.
    Osaka H; Sugiyama N; Taylor P
    J Biol Chem; 1998 May; 273(21):12758-65. PubMed ID: 9582301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-conotoxin residues that interact at close range with gamma-tyrosine-111 and mutant delta-tyrosine-113 on the Torpedo nicotinic acetylcholine receptor.
    Vélez-Carrasco W; Valdés S; Agresar L; Lettich A; Guerra AY; Hann RM
    Biochemistry; 2004 Oct; 43(39):12700-8. PubMed ID: 15449960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of endplate nicotinic acetylcholine receptors by agonists.
    Auerbach A
    Biochem Pharmacol; 2015 Oct; 97(4):601-608. PubMed ID: 26206191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of amino acids in the nicotinic acetylcholine receptor agonist binding site and ion channel photolabeled by 4-[(3-trifluoromethyl)-3H-diazirin-3-yl]benzoylcholine, a novel photoaffinity antagonist.
    Chiara DC; Trinidad JC; Wang D; Ziebell MR; Sullivan D; Cohen JB
    Biochemistry; 2003 Jan; 42(2):271-83. PubMed ID: 12525154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-conotoxins.
    Arias HR; Blanton MP
    Int J Biochem Cell Biol; 2000 Oct; 32(10):1017-28. PubMed ID: 11091135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of nicotinic receptor subunit composition upon agonist, alpha-bungarotoxin and insecticide (imidacloprid) binding affinity.
    Lansdell SJ; Millar NS
    Neuropharmacology; 2000 Feb; 39(4):671-9. PubMed ID: 10728888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of d-tubocurarine analogs with the Torpedo nicotinic acetylcholine receptor. Methylation and stereoisomerization affect site-selective competitive binding and binding to the noncompetitive site.
    Pedersen SE; Papineni RV
    J Biol Chem; 1995 Dec; 270(52):31141-50. PubMed ID: 8537377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist self-inhibitory binding site of the nicotinic acetylcholine receptor.
    Arias HR
    J Neurosci Res; 1996 Apr; 44(2):97-105. PubMed ID: 8723217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel long-chain neurotoxins from
    Utkin YN; Kuch U; Kasheverov IE; Lebedev DS; Cederlund E; Molles BE; Polyak I; Ivanov IA; Prokopev NA; Ziganshin RH; Jornvall H; Alvelius G; Chanhome L; Warrell DA; Mebs D; Bergman T; Tsetlin VI
    Biochem J; 2019 Apr; 476(8):1285-1302. PubMed ID: 30944155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The steroid promegestone is a noncompetitive antagonist of the Torpedo nicotinic acetylcholine receptor that interacts with the lipid-protein interface.
    Blanton MP; Xie Y; Dangott LJ; Cohen JB
    Mol Pharmacol; 1999 Feb; 55(2):269-78. PubMed ID: 9927618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An alpha-bungarotoxin-binding sequence on the Torpedo nicotinic acetylcholine receptor alpha-subunit: conservative amino acid substitutions reveal side-chain specific interactions.
    McLane KE; Wu X; Conti-Tronconi BM
    Biochemistry; 1994 Mar; 33(9):2576-85. PubMed ID: 8117719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acids outside of the loops that define the agonist binding site are important for ligand binding to insect nicotinic acetylcholine receptors.
    Liu Z; Han Z; Liu S; Zhang Y; Song F; Yao X; Gu J
    J Neurochem; 2008 Jul; 106(1):224-30. PubMed ID: 18363827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of d-tubocurarine analogs with the mouse nicotinic acetylcholine receptor. Ligand orientation at the binding site.
    Papineni RV; Pedersen SE
    J Biol Chem; 1997 Oct; 272(40):24891-8. PubMed ID: 9312090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist-induced displacement of quinacrine from its binding site on the nicotinic acetylcholine receptor: plausible agonist membrane partitioning mechanism.
    Arias HR
    Mol Membr Biol; 1995; 12(4):339-47. PubMed ID: 8747279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.